Larisa H. Cavallari, Pharm.D.

Larisa H. Cavallari

Associate Professor & Director, Center for Pharmacogenomics

Pharmacotherapy and Translational Research



PHONE: 352-273-8245

CV: Link to CV



  • Pharm.D. University of Georgia College of Pharmacy
  • B.S. Pharmacy, University of Georgia College of Pharmacy
  • Cardiovascular Pharmacogenomics Research Fellowship, University of Florida College of Pharmacy
  • Pharmacy Practice Residency, Veterans Affairs Medical Center, Memphis, Tennessee

Biographical Sketch

Dr. Cavallari received her B.S. Pharmacy and Pharm.D. degrees from the University of Georgia. She then completed a Pharmacy Practice Residency at the Veterans Affairs Medical Center in Memphis, Tennessee and a fellowship in Cardiovascular Pharmacogenomics at the University of Florida. Dr. Cavallari accepted a position as an Assistant Professor of Pharmacy Practice at the University of Illinois at Chicago after completing her training and was promoted to Associate Professor in 2009. While at UIC, she directed efforts to implement genotype-guided warfarin dosing for all patients newly starting warfarin during hospitalization. Dr. Cavallari joined the University of Florida Department of Pharmacotherapy and Translational Research as an Associate Professor in April, 2014, where she serves as director of the Center for Pharmacogenomics.She also serves as Associate Director of the UF Health Personalized Medicine Program. Her research involves discovery and clinical translation of genetic variants related to drug response and has been funded by the NIH, FDA, American Heart Association, and other awards.

Dr. Cavallari has served on both NIH and American Heart Association grant review committees and is a Board Certified Pharmacotherapy Specialist, Fellow of the American College of Clinical Pharmacy, former Chair of the American College of Clinical Pharmacy Research Institute, and Editorial Board Member for the Lexi-Comp pharmacogenetics series.

Professional Affiliations

  • American College of Clinical Pharmacy
  • American Heart Association
  • American Society of Clinical Pharmacology and Therapeutics
  • Clinical Pharmacogenetics Implementation Consortium
  • International Warfarin Pharmacogenetics Consortium
  • Pharmacogenomics Research Network


  • Elected Trustee, Research Institute, American College of Clinical Pharmacy, 2013 to 2016
  • Best Paper, 2009 International Congress on Clinical Pharmacy
  • Kenneth F. Finger Fellow Alumni Lecturer Award, University of Florida, 2009
  • Fellow, American College of Clinical Pharmacy, elected 2008
  • Hans Vahlteich Research Award, College of Pharmacy, University of Illinois at Chicago, 2007
  • American Association of Colleges of Pharmacy-American Foundation for Pharmaceutical Education Pharmacy Faculty New Investigator, 2004
  • Kenneth F. Finger Memorial Award for Excellence in Clinical Pharmacy Research, University of Florida, 2000
  • American College of Clinical Pharmacy 2000 Annual Meeting Best Student, Resident, Fellow Paper Award Competition
  • Kenneth F. Finger Memorial Award for Excellence in Clinical Pharmacy Research, University of Florida, 2000
  • American College of Clinical Pharmacy 2000 Annual Meeting Best Student, Resident, Fellow Paper Award Competition
  • Fellow, American Foundation for Pharmaceutical Education for the Biomedical Research Sciences, University of Florida, 1999-2000

Select Publications

Arwood MJ, Deng J, Drozda K, Pugach O, Nutescu EA, Schmidt S, Duarte JD, Cavallari LH. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: a proposal for a new pharmacogenetic dosing approach. Clin Pharmacol Ther 2017 May;101(5):675-83

Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, Hiemenz JW, Schmidt S, Langaee TY, Peloquin CA, Johnson JA, Cavallari LH. Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics 2017 May;27(5):190-6

Cavallari LH, Lee CR, Beitelshees AL, Cooper-DeHoff RM, Duarte JD, Voora D, Kimmel SE, McDonough CW, Gong Y, Dave CV, Pratt VM, Alestock TD, Anderson RD, Alsip J, Ardati AK, Brott BC, Brown L, Chumnumwat S, Clare-Salzler MJ, Coons JC, Denny JC, Dillon C, Elsey AR, Hamadeh I, Harada S, Hillegass WB, Hines L, Horenstein RB, Howell LA, Jeng LJB, Kelemen MD, Lee YM, Magvanjav O, Montasser M, Nelson DR, Nutescu EA, Nwaba DC, Pakyz RE, Palmer K, Peterson JF, Pollin TI, Quinn AH, Robinson SW, Schub J, Skaar TC, Smith DM, Sriramoju VB, Starostik P, Stys TP, Stevenson JM, Varunok N, Vesely MR, Wake DT, Weck KE, Weitzel KW, Wilke RA, Willig J, Zhao RY, Kreutz RP, Stouffer GA, Empey PE, Limdi NA, Shuldiner AR, Winterstein AG, Johnson JA. Multi-site Investigation of Outcomes with Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy after Percutaneous Coronary Intervention. JACC Cardiovasc Interv [In press]

Full Publication List via PubMed